公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2019 | Maintenance BEZ235 Treatment Prolongs the Therapeutic Effect of the Combination of BEZ235 and Radiotherapy for Colorectal Cancer | YU-HSUAN CHEN ; CHUN-WEI WANG ; Wei M.-F.; Tzeng Y.-S.; KENG-HSUEH LAN ; ANN-LII CHENG ; SUNG-HSIN KUO | Cancers | 9 | 9 | |
2018 | Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan | Wang, CK; MING-CHIH HO ; Su C.-W.; Wang T.-E.; Dai C.-Y.; CHIEN-HUNG CHEN ; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; PO-HUANG LEE ; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Lin S.-M.; GUAN-TARN HUANG ; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; PO-CHIN LIANG ; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; ANN-LII CHENG ; CHIUN HSU ; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; CHIA-HSIEN CHENG ; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; YEN-HSUAN NI ; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group; Surveillance group; Diagnosis group; Staging group; Surgery group; TACE/TARE/HAI group; Target therapy/systemic therapy group; Radiotherapy group; Prevention group; Drafting group | Journal of the Formosan Medical Association = Taiwan yi zhi | 90 | 87 | |
2012 | Management of colon cancer: Resource-stratified guidelines from the Asian Oncology Summit 2012 | Ku G.; Tan I.B.; Yau T.; Boku N.; Laohavinij S.; ANN-LII CHENG ; Kang Y.-K.; de Lima Lopes G. | The Lancet Oncology | 66 | 61 | |
2013 | Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells | Tai W.-T.; Shiau C.-W.; Chen H.-L.; Liu C.-Y.; Lin C.-S.; ANN-LII CHENG ; PEI-JER CHEN ; Chen K.-F. | Cell Death and Disease | 159 | 159 | |
2011 | Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib | Harmon C.S.; DePrimo S.E.; Raymond E.; ANN-LII CHENG ; Boucher E.; Douillard J.-Y.; Lim H.Y.; Kim J.S.; Lechuga M.J.; Lanzalone S.; Lin X.; Faivre S. | Journal of Translational Medicine | 21 | 20 | |
2012 | Medulloblastoma in adults: Treatment outcome, relapse patterns, and prognostic factors | SHIH-FAN LAI ; CHUN-WEI WANG ; YU-HSUAN CHEN ; KENG-HSUEH LAN ; CHIA-HSIEN CHENG ; ANN-LII CHENG ; SUNG-HSIN KUO | Strahlentherapie und Onkologie | 12 | 11 | |
1998 | Megestrol acetate antagonizes cisplatin cytotoxicity | YEONG-SHIAU PU ; ANN-LII CHENG ; Chen J.; Guan J.-Y.; Lu S.-H.; Lai M.-K.; CHANG-YAO HSIEH | Anti-Cancer Drugs | 3 | 3 | |
1991 | Menadione-induced DNA damage in a human tumor cell line | Ngo E.O.; Sun T.-P.; Chang J.-Y.; Wang C.-C.; Chi K.-H.; ANN-LII CHENG ; Nutter L.M. | Biochemical Pharmacology | 69 | 75 | |
1991 | Menadione: Spectrum of anticancer activity and effects on nucleotide metabolism in human neoplastic cell lines | Nutter L.M.; ANN-LII CHENG ; Hsiao-Ling H.; Ruey-Kun H.; Ngo E.O.; Tsang-Wu L. | Biochemical Pharmacology | 120 | 122 | |
2000 | Metaplastic carcinoma of the breast-analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type breast cancer | SUNG-HSIN KUO ; Chen C.-L.; CHIUN-SHENG HUANG ; ANN-LII CHENG | Anticancer Research | 31 | 28 | |
2012 | Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer | LI-CHUN LU ; YU-YUN SHAO ; CHIH-HUNG HSU ; CHIUN HSU ; WEN-FANG CHENG ; YU-LIN LIN ; ANN-LII CHENG ; KUN-HUEI YEH | Anticancer Research | 0 | | |
2020 | Milestones in the pathogenesis and management of primary liver cancer | Nault J.-C.; ANN-LII CHENG ; Sangro B.; Llovet J.M. | Journal of Hepatology | 39 | 35 | |
2000 | Minimal toxicity to myeloid progenitor cells of weekly 24-hr infusion of high-dose 5-fluorouracil: Direct evidence from colony forming unit- granulocyte and monocyte (CFU-GM) clonogenic assay | KUN-HUEI YEH ; Shiou-Hwei Yeh ; Chang Y.-S.; ANN-LII CHENG | Pharmacology and Toxicology | 15 | 12 | |
2016 | Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma | YU-YUN SHAO ; TSUNG-HAO LIU ; Lee, Ying-Hui; CHIH-HUNG HSU ; ANN-LII CHENG | J. Gastroenterol. Hepatol. | 26 | 24 | |
1994 | Modulation of retinoic acid receptor alpha, growth factor and proto-oncogenes in retinoic acid-induced apoptosis of Ki-1 lymphoma cell line | Su I.-J.; Lay Z.-D.; ANN-LII CHENG ; Chang Y.-C. | International Journal of Oncology | 6 | | |
2009 | Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia | CHING-HUNG LIN ; JAU-YU LIAU ; YEN-SHEN LU ; CHIUN-SHENG HUANG ; Lee W.-C.; KUAN-TING KUO ; Ying-Chun Shen ; SUNG-HSIN KUO ; Lan C.; Liu J.M.; WEN-HUNG KUO ; KING-JEN CHANG ; ANN-LII CHENG | Cancer Epidemiology Biomarkers and Prevention | 99 | 95 | |
2007 | Molecular targeted therapy for advanced hepatocellular carcinoma | Ying-Chun Shen ; CHIUN HSU ; ANN-LII CHENG | Targeted Oncology | 6 | 4 | |
2010 | Molecular targeted therapy for advanced hepatocellular carcinoma: Current status and future perspectives | Ying-Chun Shen ; CHIUN HSU ; ANN-LII CHENG | Journal of Gastroenterology | 61 | 54 | |
2017 | mRECIST to predict survival in advanced hepatocellular carcinoma: Analysis of two randomised phase II trials comparing nintedanib vs sorafenib | Meyer T.; Palmer D.H.; ANN-LII CHENG ; Hocke J.; Loemb? A.-B.; Yen C.-J. | Liver International | 59 | 49 | |
2020 | A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy | ZHONG-ZHE LIN ; BANG-BIN CHEN ; Hung, Yi-Ping; HUANG, PO-HSIANG ; Ying-Chun Shen ; YU-YUN SHAO ; CHIH-HUNG HSU ; ANN-LII CHENG ; Lee, Rheun-Chuan; Chao, Yee; CHIUN HSU | Oncologist | 12 | 10 | |